EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of a pharmacist-driven insulin dispensing program in a management services organization

Tina Benny, Marija Lapkus, Genevieve Hale, Cynthia Moreau, Alexandra Perez, Erika Zwachte

JAPhA Practice Innovations · 2024

DOI: 10.1016/j.japhpi.2024.100010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAPhA Practice Innovations, 2024. Verfasst von Tina Benny und 5 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin prices have tripled in the United States over the past decade. The affordability of insulin products may affect patient adherence and, as a result, glucose control. Providers may need to consider less expensive insulin options to improve patient outcomes.

Objective

This study aimed to evaluate the impact of a low-cost, in-office insulin dispensing program led by pharmacists in a management services organization on patient glucose control, adherence to routine laboratory tests, and patient satisfaction.

Methods

This multicenter, retrospective cohort study was conducted at 2 primary care clinics in South Florida. The primary outcome was the change in mean hemoglobin A1c (HbA1c) at baseline versus 6 months after insulin program enrollment. The secondary outcomes included mean HbA1c at baseline versus 12 months after insulin program enrollment, patient satisfaction evaluated with a survey, and adherence to routine laboratory tests, specifically HbA1c and urine albumin to creatinine ratio before and after enrollment.

Results

A total of 21 patients met inclusion criteria. The mean HbA1c before program enrollment was 9.4% compared with a mean HbA1c of 8.6% 6 months after enrollment ( P = 0.058) and 8.4% 12 months after enrollment when available ( P = 0.097). Of the 12 patients who completed the patient satisfaction survey, 11 (91.7%) agreed or strongly agreed that they were satisfied with pharmacist involvement in insulin management and planned to continue using the insulin program.

Conclusion

Among patients with type 2 diabetes enrolled in a low-cost, in-office insulin program, change in mean HbA1c after 6 and 12 months was not statistically significant.

Zitieren

APA

Benny, T., Lapkus, M., Hale, G., Moreau, C., Perez, A., & Zwachte, E. (2024). Impact of a pharmacist-driven insulin dispensing program in a management services organization. JAPhA Practice Innovations. https://doi.org/10.1016/j.japhpi.2024.100010

Vancouver

Benny T, Lapkus M, Hale G, Moreau C, Perez A, Zwachte E. Impact of a pharmacist-driven insulin dispensing program in a management services organization. JAPhA Practice Innovations. 2024. doi:10.1016/j.japhpi.2024.100010

BibTeX
@article{Benny2024,
  author = {Benny, Tina and Lapkus, Marija and Hale, Genevieve and Moreau, Cynthia and Perez, Alexandra and Zwachte, Erika},
  title = {Impact of a pharmacist-driven insulin dispensing program in a management services organization},
  journal = {JAPhA Practice Innovations},
  year = {2024},
  doi = {10.1016/j.japhpi.2024.100010}
}
Kostenlos starten →